Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review

• Main Authors: Silvia Marquez-Megias (Author), Ricardo Nalda-Molina (Author), Javier Sanz-Valero (Author), Patricio Más-Serrano (Author), Marcos Diaz-Gonzalez (Author), Maria Remedios Candela-Boix (Author), Amelia Ramon-Lopez (Author)
• Format: Book
• Published: MDPI AG, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Infliximab and adalimumab are monoclonal antibodies against tumor necrosis factor (anti-TNF) used to manage inflammatory bowel disease (IBD). Therapeutic Drug Monitoring (TDM) has been proven to prevent immunogenicity, to achieve better long-term clinical results and to save costs in IBD treatment....